Alkaline phosphatase may originate from liver/biliary tissue or bone. Bilirubin reflects heme breakdown, hepatic handling, and excretion. Together with AST/ALT and bilirubin fractionation when useful, they help identify cholestatic/obstructive patterns, hepatocellular disease, hemolysis/conjugation disorders, or nonhepatic alk phos sources.
CLINICAL PRINTABLE
Coming Soon.
Coming Soon. A one-page Alkaline Phosphatase + Bilirubin clinical reference is on the way.
- Alkaline phosphatase (alk phos) is produced by the liver/biliary epithelium, bone, intestine, placenta, and kidneys. An isolated alk phos elevation requires confirmation of hepatic origin before liver workup.
- GGT (gamma-glutamyl transferase) is liver-specific — a concurrent GGT elevation confirms hepatic origin of alk phos. GGT alone is not a useful standalone marker.
- Bilirubin reflects heme breakdown (unconjugated) and hepatic conjugation/excretion (conjugated). Fractionation changes the differential: unconjugated hyperbilirubinemia suggests hemolysis or Gilbert syndrome; conjugated suggests hepatocellular disease or biliary obstruction.
- Cholestatic pattern: alk phos and GGT elevated out of proportion to AST/ALT. Causes include biliary obstruction (choledocholithiasis, malignancy, stricture), primary biliary cholangitis, primary sclerosing cholangitis, and drug-induced cholestasis.
- Hepatocellular pattern: AST/ALT elevated out of proportion to alk phos. Cholestatic and hepatocellular patterns can coexist (mixed pattern).
- Jaundice (visible bilirubin elevation) typically appears when total bilirubin exceeds 2.5–3 mg/dL. Scleral icterus is often the earliest visible sign.
Bone-derived alk phos
Bone disease (Paget's disease, bone metastases, healing fractures, hyperparathyroidism, osteomalacia) can markedly elevate alk phos without liver disease. GGT is normal in bone-derived elevation. Bone-specific alk phos isoenzyme or imaging can confirm.
Physiologic elevation
Alk phos is physiologically elevated in pregnancy (placental isoenzyme), adolescence (bone growth), and after fatty meals (intestinal isoenzyme). These are not liver disease.
Gilbert syndrome
Gilbert syndrome is a benign, common cause of mild unconjugated hyperbilirubinemia — typically < 3 mg/dL, exacerbated by fasting, illness, or stress. Liver enzymes and synthetic function are normal. No treatment is needed.
Cholangitis
Charcot's triad (jaundice + fever + RUQ pain) suggests acute cholangitis — a medical emergency requiring urgent biliary decompression. Reynolds' pentad adds hypotension and altered mental status, indicating severe/suppurative cholangitis.
Medications and cholestasis
Drug-induced cholestasis can mimic biliary obstruction — common culprits include amoxicillin-clavulanate, fluoroquinolones, anabolic steroids, and many others. Always review the medication list before imaging for obstruction.
- Jaundice + fever + RUQ pain (Charcot's triad) — suspect acute cholangitis. This is a medical emergency requiring urgent biliary decompression and antibiotics.
- Painless jaundice with weight loss and elevated alk phos — raises concern for pancreatic or biliary malignancy. Urgent imaging is warranted.
- Conjugated hyperbilirubinemia with cholestatic enzymes — requires biliary imaging (RUQ ultrasound first) to evaluate for obstruction.
- Rising bilirubin with impaired synthetic function (elevated INR, low albumin) — suggests hepatic failure, not isolated cholestasis.
- Classify the pattern: cholestatic, hepatocellular, or mixed. Then confirm hepatic origin of alk phos with GGT if needed.
- Fractionate bilirubin if the mechanism is unclear — conjugated vs. unconjugated changes the differential significantly.
- For cholestatic pattern: RUQ ultrasound is the first imaging step to evaluate for biliary dilation and obstruction.
- Review medications and supplements — drug-induced cholestasis is common and reversible.
- Assess synthetic function (INR, albumin) to determine severity and guide urgency of hepatology referral.
CASE 1
A 62-year-old with known Paget's disease has alk phos 480 U/L on routine labs. GGT is normal. AST, ALT, and bilirubin are normal. The elevation is bone-derived — no liver workup is initiated. Bone-specific alk phos confirms Paget's activity.
CASE 2
A 55-year-old presents with jaundice, fever, and RUQ pain. Alk phos is 620 U/L, total bilirubin 4.8 mg/dL (predominantly conjugated), GGT elevated. RUQ ultrasound shows biliary dilation. Acute cholangitis is diagnosed — urgent ERCP and antibiotics are initiated.
NOW CHANGE ONE DETAIL
Same patient as Case 2, but there is no fever or pain — only painless jaundice and a 15-pound weight loss over 2 months. The painless presentation with weight loss raises concern for pancreatic head malignancy. CT abdomen/pelvis with contrast is ordered urgently.
Bottom Line
Pattern first: hepatocellular, cholestatic, mixed, or nonhepatic. Then confirm hepatic origin, fractionate bilirubin, and let imaging and context guide the next step.
EVIDENCE & REFERENCES
- Kwo PY, et al. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18–35. doi:10.1038/ajg.2016.517
- Barkun AN, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152(2):101–113. doi:10.7326/0003-4819-152-2-201001190-00009
- Hirschfield GM, et al. Primary biliary cholangitis. Lancet. 2018;392(10146):516–529. doi:10.1016/S0140-6736(18)31648-7